SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2 trial expected by 2027, aimed at entering the high-immunogenicity vaccine market "Our SKYCellflu platform with our adjuvanted vaccine experience will lay a strong foundation for future success." SEONGNAM, South...
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million...
SpaceGut Marks World Microbiome Day with Science-Backed Solution for Malaysia’s Obesity Issue
KUALA LUMPUR, Malaysia, July 17, 2025 /PRNewswire/ -- In celebration of World Microbiome Day, SpaceGut, a Malaysia-based health tech company, introduces a scientific and personalised approach to one of the country's most pressing health concerns, obesity. Through its Gut Microbiome Test Kit and AI-powered personalised meal plan, SpaceGut aims to address the root microbial imbalances that contribute to excessive...
Vietnam’s Dairy Pride: Vinamilk Makes Headlines at Growth Asia Summit with 6-HMO Breakthrough
SINGAPORE, July 17, 2025 /PRNewswire/ -- At the Growth Asia Summit 2025, which took place from July 15–17 in Singapore, Vinamilk was honored to be the only Vietnamese company invited as a keynote speaker. The Growth Asia Summit is the largest forum for growth opportunities in the food, beverage, and nutrition industries in Asia. The brand made a remarkable...
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam
YONGIN, South Korea, July 17, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam (DAV). Following domestic approval in 2020 and WHO Pre-Qualification (PQ) in 2023, GC Biopharma has been accelerating individual country registrations...
Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tübingen
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and diagnostics for malaria and tuberculosis (TB).2 Investment of JPY 800 million (USD 5.5 million1) in malaria vaccine project Malaria is a serious infectious...
Unlocking New Opportunities in Asia and the Greater Bay Area
SHANGHAI, July 17, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, fostering meaningful connections across the entire pharmaceutical supply chain. This remarkable success is a testament to the strong demand within China's thriving pharma industry. Building on this momentum, CPHI & PMEC Shenzhen 2025 will take place from 1-3 September 2025 at...
Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
SAN FRANCISCO and SUZHOU, China, July 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that Nature Medicine (IF: 58.7) has published the results of the Phase 1 clinical study of IBI343, an innovative...
Health In Tech Supports Foster Closet to Help Children and Families in Need
STUART, Fla., July 17, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce its financial support for Community Foster Closet, a local nonprofit in Spokane Valley, Washington, dedicated to providing free clothing, shoes, diapers, wipes, and other essentials to foster families...
Flat Medical Honored at Premier, Inc.’s Annual Supplier Innovation Celebration
AUSTIN, Texas, July 16, 2025 /PRNewswire/ -- FlatTech LLC, doing business as Flat Medical today announced that it was honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2025 Breakthroughs Conference and Exhibition. The Innovation Celebration recognizes groundbreaking healthcare technologies that have been launched throughout the year and the ways these products are helping to improve the health...
